Sparrow Pharmaceuticals

Drug DiscoveryWebsite
Current Valuation
$139.0M
As of September 24, 2025
Total Funding Raised
$145.8M
Across 1 round
Last Round
Later Stage VC

$95.0M

Last Funding
Sep 2025

Funding date

Capital Efficiency
0.95x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
September 24, 2025Later Stage VC (Series B)$95.0MN/A-
Valuation Analysis

Current Valuation Metrics

Sparrow Pharmaceuticals is currently valued at $139.0M as of September 24, 2025. The company has raised a total of $145.8M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 0.95x, Sparrow Pharmaceuticals has achieved a valuation that is 0.95 times the total capital raised.

Track Sparrow Pharmaceuticals Valuation Updates

Get notified when Sparrow Pharmaceuticals raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Sparrow Pharmaceuticals's valuation history, funding rounds, and growth metrics.

No credit card required

What is Sparrow Pharmaceuticals Worth in 2026?

Sparrow Pharmaceuticals is a leading private company in the Drug Discovery sector. Track Sparrow Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Sparrow Pharmaceuticals Valuation is Determined

Private company valuations like Sparrow Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.